Ortiga-Carvalho TM, Chiamolera MI, Pazos-Moura CC, Wondisford FE. Hypothalamus-pituitary-thyroid axis. Compr Physiol. 2011;6(3):1387–428.
Piekiełko-Witkowska A, Nauman A. Iodothyronine deiodinases and cancer. J Endocrinol Invest. 2011;34(9):716–28.
Davis PJ, Goglia F, Leonard JL. Nongenomic actions of thyroid hormone. Nat Rev Endocrinol. 2016;12(2):111–21.
Article CAS PubMed Google Scholar
Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, Okosieme OE. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301–16.
Huang CH, Wei JC, Chien TC, Kuo CW, Lin SH, Su YC, Hsu CY, Chiou JY, Yeh MH. Risk of breast cancer in females with hypothyroidism: a nationwide, population-based, cohort study. Endocr Pract. 2021;27(4):298–305.
Kirkegård J, Farkas DK, Jørgensen JOL, Cronin-Fenton D. Hyper- and hypothyroidism and gastrointestinal cancer risk: a Danish nationwide cohort study. Endocr Connect. 2018;7(11):1129–35.
Article PubMed PubMed Central Google Scholar
Søgaard M, Farkas DK, Ehrenstein V, Jørgensen JO, Dekkers OM, Sørensen HT. Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study. Eur J Endocrinol. 2016;174(4):409–14.
Yeh NC, Chou CW, Weng SF, Yang CY, Yen FC, Lee SY, Wang JJ, Tien KJ. Hyperthyroidism and thyroid cancer risk: a population-based cohort study. Exp Clin Endocrinol Diabetes. 2013;121(7):402–6.
Article CAS PubMed Google Scholar
L’Heureux A, Wieland DR, Weng C-H, Chen Y-H, Lin C-H, Lin T-H, Weng C-H. Association between thyroid disorders and colorectal cancer risk in adult patients in Taiwan. JAMA Netw Open. 2019;2(5):e193755–e193755.
Article PubMed PubMed Central Google Scholar
Wolf AM, Fontham ET, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YCT. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society. CA: Cancer J Clin. 2018;68(4):250–281.
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–91.
Rennert G, Rennert HS, Pinchev M, Gruber SB. A case-control study of levothyroxine and the risk of colorectal cancer. J Natl Cancer Inst. 2010;102(8):568–72.
Article CAS PubMed PubMed Central Google Scholar
Chen YK, Lin CL, Cheng FT, Sung FC, Kao CH. Cancer risk in patients with Hashimoto’s thyroiditis: a nationwide cohort study. Br J Cancer. 2013;109(9):2496–501.
Article PubMed PubMed Central Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.
Article PubMed PubMed Central Google Scholar
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45(Pt A):139–45.
Article PubMed PubMed Central Google Scholar
Chandler J, Cumpston M, Li T. Cochrane handbook for systematic reviews of interventions.
van Enst WA, Ochodo E, Scholten RJ, Hooft L, Leeflang MM. Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study. BMC Med Res Methodol. 2014;14(1):1–11.
Mansoor E, Chouhan V, Abou Saleh M, Sheriff ZM, Cooper GS. 330 increased risk of colorectal cancer in individuals with hypothyroidism and hyperthyroidism: results from a population-based national study. Offic J Am Coll Gastroenterol | ACG. 2019;114:S194.
Kirkegård J, Farkas DK, Jørgensen JOL, Cronin-Fenton DP. Hyperthyroidism or hypothyroidism and gastrointestinal cancer risk: a Danish nationwide cohort study. Endocr Connect. 2018;7(11):1129–35.
Article PubMed PubMed Central Google Scholar
Chan YX, Knuiman MW, Divitini ML, Brown SJ, Walsh J, Yeap BB. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer. Eur J Endocrinol. 2017;177(4):297–308.
Article CAS PubMed Google Scholar
Chan YX, Alfonso H, Chubb SAP, Fegan PG, Hankey GJ, Golledge J, Flicker L, Yeap BB. Higher thyrotropin concentration is associated with increased incidence of colorectal cancer in older men. Clin Endocrinol. 2017;86(2):278–85.
Mu G, Mu X, Xing H, Xu R, Sun G, Dong C, Pan Q, Xu C. Subclinical hypothyroidism as an independent risk factor for colorectal neoplasm. Clin Res Hepatol Gastroenterol. 2015;39(2):261–6.
Boursi B, Haynes K, Mamtani R, Yang Y-X. Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk. J Natl Cancer Inst. 2015;107(6):djv084.
Chen Y-K, Lin C-L, Chang Y-J. Cheng FT-F, Peng C-L, Sung F-C, Cheng Y-H, Kao C-H. Cancer risk in patients with Graves’ disease: a nationwide cohort study. Thyroid. 2013;23(7):879–84.
Hellevik AI, Åsvold BO, Bjøro T, Romundstad PR, Nilsen TIL, Vatten LJ. Thyroid function and cancer risk: a prospective population study. Cancer Epidemiology and Prevention Biomarkers. 2009;18(2):570–4.
Kuiper JG, Fenneman AC, van der Spek AH, Rampanelli E, Nieuwdorp M, van Herk-Sukel MP, Lemmens VE, Kuipers EJ, Herings RM, Fliers E. Levothyroxine use and the risk of colorectal cancer: a large population-based case–control study. Endocr Connect. 2022;11(1).
Wu CC, Islam MM, Nguyen PA, Poly TN, Wang CH, Iqbal U, Li YCJ, Yang HC. Risk of cancer in long-term levothyroxine users: retrospective population-based study. Cancer Sci. 2021;112(6):2533.
Article CAS PubMed PubMed Central Google Scholar
Rennert G, Rennert HS, Pinchev M, Gruber SB. A case–control study of levothyroxine and the risk of colorectal cancer. J Natl Cancer Inst. 2010;102(8):568–72.
Article CAS PubMed PubMed Central Google Scholar
Kuiper JG, Fenneman AC, van der Spek AH, Rampanelli E, Nieuwdorp M, van Herk-Sukel MPP, Lemmens V, Kuipers EJ, Herings RMC, Fliers E. Levothyroxine use and the risk of colorectal cancer: a large population-based case-control study. Endocr Connect. 2022;11(1).
Chen Y-K, Lin C-L, Chang Y-J. Cheng FT-F, Peng C-L, Sung F-C, Cheng Y-H, Kao C-H. Cancer risk in patients with Graves’ disease: a nationwide cohort study. Thyroid Offic J Am Thyroid Assoc. 2013;23(7):879–84.
Boursi B, Haynes K, Mamtani R, Yang YX. Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk. J Natl Cancer Inst. 2015;107(6).
L’Heureux A, Wieland DR, Weng CH, Chen YH, Lin CH, Lin TH, Weng CH. Association between thyroid disorders and colorectal cancer risk in adult patients in Taiwan. JAMA Netw Open. 2019;2(5).
Kirkegård J, Farkas DK, Jørgensen JOL, Fenton DPC. Hyperthyroidism or hypothyroidism and gastrointestinal cancer risk: a Danish nationwide cohort study. Endocr Connect. 2018;7(11):1129–35.
Article PubMed PubMed Central Google Scholar
Alikhan M, Mansoor E, Panhwar MS, Abou Saleh M, Chouhan V, Sheriff MZ, Cooper GS. Increased risk of colorectal cancer in individuals with hypothyroidism and hyperthyroidism: results from a population-based national study. Gastroenterology. 2020;158(6):S499–500.
Krashin E, Piekiełko-Witkowska A, Ellis M, Ashur-Fabian O. Thyroid hormones and cancer: a comprehensive review of preclinical and clinical studies. Front Endocrinol. 2019;10:59.
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przeglad gastroenterologiczny. 2019;14(2):89–103.
CAS PubMed PubMed Central Google Scholar
Rostkowska O, Spychalski P, Dobrzycka M, Wilczyński M, Łachiński AJ, Obołończyk Ł, Sworczak K, Kobiela J. Effects of thyroid hormone imbalance on colorectal cancer carcinogenesis and risk - a systematic review. Endokrynol Pol. 2019;70(2):190–7.
Article CAS PubMed Google Scholar
Lars CM, Dagmar F. Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. Endocr Relat Cancer. 2013;20(2):R19–29.
Khan SR, Chaker L, Ruiter R, Aerts JGJV, Hofman A, Dehghan A, Franco OH, Stricker BHC, Peeters RP. Thyroid function and cancer risk: the Rotterdam study. J Clin Endocrinol Metab. 2016;101(12):5030–6.
Article CAS PubMed Google Scholar
Boursi B, Haynes K, Mamtani R, Yang Y-X. Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk. JNCI: J Natl Cancer Inst. 2015;107(6).
Liu Y-C, Yeh C-T, Lin K-H. Molecular functions of thyroid hormone signaling in regulation of cancer progression and anti-apoptosis. Int J Mol Sci. 2019;20(20):4986.
Article CAS PubMed PubMed Central Google Scholar
Zhu L, Tian G, Yang Q, De G, Zhang Z, Wang Y, Nie H, Zhang Y, Yang X, Li J. Thyroid hormone receptor β1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells. Oncol Rep. 2016;36(3):1419–26.
Article CAS PubMed Google Scholar
Brown AR, Simmen RCM, Simmen FA. The role of thyroid hormone signaling in the prevention of digestive system cancers. Int J Mol Sci. 2013;14(8):16240–57.
Article PubMed PubMed Central Google Scholar
Dentice M, Luongo C, Ambrosio R, Sibilio A, Casillo A, Iaccarino A, Troncone G, Fenzi G, Larsen PR, Salvatore D. β-catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells. Gastroenterology. 2012;143(4):1037–47.
Article CAS PubMed Google Scholar
Shimi G, Zand H, Pourvali K, Ghorbani A. Colorectal cancer causes alteration of thyroid hormone profile in newly diagnosed patients. Expert Rev Endocrinol Metab. 2021;16(5):259–62.
Article CAS PubMed Google Scholar
Deligiorgi MV, Trafalis DT. The intriguing thyroid hormones-lung cancer association as exemplification of the thyroid hormones-cancer association: three decades of evolving research. Int J Mol Sci. 2021;23(1):436.
Comments (0)